|
63
|
231
|
5lttE |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
66
|
231
|
5l5aE |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
68
|
242
|
5l67D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
45
|
223
|
5a5b2 |
Structure of the 26s proteasome-ubp6 complex |
|
70
|
233
|
5jhrM |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
65
|
241
|
5jhrG |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
37
|
198
|
5a0qM |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
45
|
198
|
5a5b4 |
Structure of the 26s proteasome-ubp6 complex |
|
72
|
243
|
5jhrF |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
62
|
242
|
5a5bD |
Structure of the 26s proteasome-ubp6 complex |
|
65
|
242
|
5jhsD |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 15 |
|
44
|
197
|
5a0qN |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
59
|
196
|
5bouN |
Yeast 20s proteasome in complex with a beta1 / beta2 specific non-peptidic sulfonamide ligand |
|
67
|
229
|
4z1lM |
Yeast 20s proteasome in complex with belactosin c derivative 3 |
|
43
|
189
|
5a0qK |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
60
|
243
|
5a0qC |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
51
|
224
|
5a0qE |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
57
|
202
|
5gjqa |
Structure of the human 26s proteasome bound to usp14-ubal |
|
57
|
234
|
5gjqF |
Structure of the human 26s proteasome bound to usp14-ubal |
|
64
|
244
|
5gjqB |
Structure of the human 26s proteasome bound to usp14-ubal |
|
53
|
199
|
5gjqd |
Structure of the human 26s proteasome bound to usp14-ubal |
|
60
|
243
|
5gjqE |
Structure of the human 26s proteasome bound to usp14-ubal |
|
57
|
233
|
5gjqC |
Structure of the human 26s proteasome bound to usp14-ubal |
|
65
|
243
|
5gjqX |
Structure of the human 26s proteasome bound to usp14-ubal |
|
58
|
238
|
5gjqG |
Structure of the human 26s proteasome bound to usp14-ubal |
|
40
|
194
|
5fmgK |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
64
|
231
|
5fg9E |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
72
|
214
|
5fgfK |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
50
|
232
|
5fmgC |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
70
|
212
|
5fg9K |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
58
|
204
|
5fgaI |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
62
|
241
|
5fgiG |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
39
|
247
|
5fmgA |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
63
|
241
|
5fgaG |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
64
|
233
|
5fgdM |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
62
|
241
|
5fg7G |
Yeast 20s proteasome beta2-t1a mutant |
|
70
|
244
|
5fgaB |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
54
|
204
|
5fgiI |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
71
|
244
|
5fg7B |
Yeast 20s proteasome beta2-t1a mutant |
|
71
|
244
|
5fgiB |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
67
|
250
|
5fghA |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
58
|
222
|
5fgeH |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
68
|
244
|
5fgfB |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
69
|
243
|
5fgeF |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
69
|
250
|
5fgfA |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
42
|
228
|
5fmgD |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
57
|
204
|
5fg9I |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
72
|
212
|
5fg7K |
Yeast 20s proteasome beta2-t1a mutant |
|
64
|
231
|
5fggE |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
71
|
240
|
5fg7C |
Yeast 20s proteasome beta2-t1a mutant |
